Literature DB >> 946579

[Initial sign and clinical course of the most severe form of acute proliferative retrolental fibroplasia (type II) (author's transl)].

H Morizane.   

Abstract

Entities:  

Mesh：

Year:  1976        PMID： 946579

Source DB:  PubMed          Journal:  Nippon Ganka Gakkai Zasshi        ISSN： 0029-0203


× No keyword cloud information.
  6 in total

1.  Intravitreal bevacizumab monotherapy for type-1 prethreshold, threshold, and aggressive posterior retinopathy of prematurity - 27 month follow-up results from Turkey.

Authors:  Huseyin Yetik; Murat Gunay; Sarkis Sirop; Ziya Salihoglu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-12-14       Impact factor: 3.117

2.  [Ophthalmological screening for retinopathy of prematurity].

Authors:  I Oberacher-Velten; H Segerer; H Helbig
Journal:  Ophthalmologe       Date:  2012-12       Impact factor: 1.059

3.  Characteristics of 'sawtooth shunt' following anti-vascular endothelial growth factor for aggressive posterior retinopathy of prematurity.

Authors:  Tapas Ranjan Padhi; Taraprasad Das; Prabhjot Kaur; Samir Sutar; Ashish Khalsa; Rohit Modi; Hasnat Ali; Lingaraj Pradhan; Subhadra Jalali
Journal:  Int Ophthalmol       Date:  2020-01-10       Impact factor: 2.031

Review 4.  Retinopathy of prematurity.

Authors:  E Bossi; F Koerner
Journal:  Intensive Care Med       Date:  1995-03       Impact factor: 17.440

Review 5.  Aggressive posterior retinopathy of prematurity: a review on current understanding.

Authors:  Devesh Kumawat; Anusha Sachan; Pooja Shah; Rohan Chawla; Parijat Chandra
Journal:  Eye (Lond)       Date:  2021-01-29       Impact factor: 3.775

6.  Capillary-free vascularized retina in patients with aggressive posterior retinopathy of prematurity and late retinal capillary formation.

Authors:  Seong Joon Ahn; Jeong Hun Kim; Seong-Joon Kim; Young Suk Yu
Journal:  Korean J Ophthalmol       Date:  2013-03-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.